Home LiteratureArticle Details
PMID: 334219 Published · ppublish English Clinical Trial Comparative Study Journal Article Randomized Controlled Trial

Repeated dose comparison of nomifensine, imipramine and placebo on subjective assessments of sleep and objective measures of psychomotor performance.

British journal of clinical pharmacology ·Vol. 4Suppl 2 ·1977-00-00 ·Pages 167S-173S

Hindmarch I, Parrott AC

Abstract

1. Nine normal subjects volunteered to participate in a randomized single-blind crossover study of nomifensine 75 mg and two comparators, imipramine 75 mg and placebo. 2. Each volunteer received placebo for 3 d, then the first test drug for 4 days. This sequence was repeated twice more, so that each subject received each comparator. All medication was taken three times daily. 3. Assessments were made on days 3, 5 and 7 of each sequence, and consisted of a Sleep Evaluation Questionnaire, a test of Critical Flicker Fusion and a measure of Complex Reaction Time (CRT). 4. There were no significant differences in the CRT. There was a significant increase in critical flicker fusion with nomifensine. 5. Although both nomifensine and imipramine disturbed the quality of sleep, only imipramine produced a hangover.

MeSH Terms
Adult Clinical Trials as Topic Female Flicker Fusion/drug effects Humans Imipramine/pharmacology Isoquinolines/pharmacology Male Middle Aged Nomifensine/pharmacology Placebos Reaction Time/drug effects Sleep/drug effects
Chemicals
Isoquinolines Placebos Nomifensine Imipramine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Hindmarch I
Parrott A C
References (10)
10 references, click to expand
  1. Dose responses and relationships between anticholinergic activity and mood with tricyclic antidepressants.
    Psychopharmacologia. 1972;25(3):205-17 PMID: 4557940
  2. Comparable therapeutic efficacy of tryptophan and imipramine: average therapeutic ratings versus "true" equivalence. An important difference.
    Curr Ther Res Clin Exp. 1973 Jul;15(7):484-7 PMID: 4198311
  3. Drowsiness and antidepressant drugs in mild depressive illness.
    Br J Psychiatry. 1972 May;120(558):507-9 PMID: 5041530
  4. [Results of an open and a double-blind study of nomifensin in comparison to imipramin (author's transl)].
    Arch Psychiatr Nervenkr (1970). 1974;219(3):265-76 PMID: 4611383
  5. The clinical pharmacology of imipramine. Implications for therapeutics.
    Arch Gen Psychiatry. 1973 May;28(5):649-53 PMID: 4573419
  6. A clinical trial with nomifensin, a new antidepressant drug.
    Int J Clin Pharmacol Biopharm. 1975 Jun;11(4):304-8 PMID: 125727
  7. 8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline, a new antidepressant.
    Arzneimittelforschung. 1973 Jan;23(1):45-50 PMID: 4740695
  8. Neurophysiological and biochemical aspects in the action of antidepressant drugs.
    Act Nerv Super (Praha). 1970;12(3):226-34 PMID: 4917579
  9. Effectiveness of antidepressant drugs: a triple-blind study comparing imipramine, desipramine, and placebo.
    Am J Psychiatry. 1971 Feb;127(8):1092-5 PMID: 4925145
  10. A 1,4-benzodiazepine, temazepam (K 3917), its effect on some psychological parameters of sleep and behaviour.
    Arzneimittelforschung. 1975 Nov;25(11):1836-9 PMID: 1106446
Article Info
Journal
British journal of clinical pharmacology
Abbr.
Br J Clin Pharmacol
ISSN
0306-5251
Published
1977-00-00
Pages
167S-173S
Language
English
Region
England
NLM ID
7503323
PMCID
PMC1429111
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]